Director, Pipeline Marketing

Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, drawing on leadership that previously played key roles in the design, development, and commercialization of cutting‑edge therapies, including antibody‑drug conjugate therapies. Our pipeline includes varegacestat, a late‑clinical stage GSI; IM‑1021, a clinical‑stage ROR1 ADC; and IM‑3050, a FAP‑targeted radiotherapy that recently received IND clearance.

We are also advancing a broad portfolio of early‑stage ADCs pursuing undisclosed solid tumor targets.

The Director of Pipeline Marketing offers a unique opportunity for an experienced, driven, and innovative individual who thrives at the intersection of science, strategy, and commercialization. This role will serve as the Pipeline Marketing lead for early‑stage programs and own Competitive Intelligence (CI) capabilities for Immunome.

The individual will play a critical role in shaping the commercial foundation of early pipeline assets and supporting advancement of a growing portfolio in an increasingly competitive landscape. Working closely with cross‑functional partners across Research, Clinical, Medical, and Business Development, this role ensures program strategy is informed by a rigorous understanding of the competitive and market environment.

The ideal candidate is highly strategic, analytically strong, and comfortable operating in a lean, fast‑moving biotech organization where early insights meaningfully influence development and investment decisions.

• Serve as pipeline marketing lead on early‑stage program(s).
• Partner with clinical development to provide commercial input on development strategies for the pipeline and commercial aspects of clinical development.
• Lead commercial assessments & business case development for clinical investment decisions including analysis of current and future treatment paradigms, competitive landscape, unmet needs, positioning, and overall commercial potential.
• Lead competitive intelligence to support varegacestat launch preparation, including monitoring of competitive activity in desmoid tumors, assessment of evolving treatment paradigms, and generation of insights to support a successful and differentiated commercial launch.
• Lead competitive intelligence in support of the broader pipeline, providing structured assessments of competitive landscapes, emerging assets, and market dynamics to inform indication prioritization, development strategy, and portfolio planning.
• Develop and deliver high‑impact CI outputs (competitive landscapes, competitor profiles, and clinical benchmarking, and scenario analysis) that translate complex data into clear strategic implications.
• Partner cross‑functionally with Commercial, Research, Clinical, Medical, and Business Development teams to ensure competitive insights are embedded into decision‑making, development planning, and long‑term strategy.

• Bachelor’s degree required;
  Advanced degree preferred.
• A minimum of 7 years of experience in the pharmaceutical or biotech industry;
  Oncology experience required.
• Launch experience preferred; US & Global experience preferred.
• A minimum of 3 years’ experience in Pipeline Marketing, New Product Planning and/or Competitive Intelligence.
• Travel 20%+ with weekend travel.

• Demonstrated cross‑functional teamwork capabilities.
• Excellent verbal and written communication skills for a wide range of audiences.
• Strong cross‑functional leadership skills and ability to influence without authority.
• Excellent strategic and analytical thinking abilities.
• Agile and adaptable with a growth mindset.

$185,100 - $250,882 USD

Immunome, Inc. is an equal opportunity employer. We celebrate diversity and are committed to creating an inclusive environment for all employees.